0001415889-24-022784.txt : 20240904 0001415889-24-022784.hdr.sgml : 20240904 20240904163414 ACCESSION NUMBER: 0001415889-24-022784 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240903 FILED AS OF DATE: 20240904 DATE AS OF CHANGE: 20240904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDGEMOND JAMES CENTRAL INDEX KEY: 0001636178 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 241278057 MAIL ADDRESS: STREET 1: 1040 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4-09042024_040904.xml X0508 4 2024-09-03 0001082554 UNITED THERAPEUTICS Corp UTHR 0001636178 EDGEMOND JAMES C/O UNITED THERAPEUTICS CORPORATION 1000 SPRING STREET SILVER SPRING MD 20910 false true false false CFO AND TREASURER 1 Common Stock 2024-09-03 4 M 0 3266 120.26 A 5881 D Common Stock 2024-09-03 4 S 0 3266 362.37 D 2615 D Common Stock 2024-09-03 4 M 0 3400 117.76 A 6015 D Common Stock 2024-09-03 4 S 0 3400 362.37 D 2615 D Common Stock 2024-09-03 4 M 0 816 120.26 A 3431 D Common Stock 2024-09-03 4 S 0 550 362.37 D 2881 D Common Stock 2024-09-03 4 M 0 850 117.76 A 3731 D Common Stock 2024-09-03 4 S 0 569 362.37 D 3162 D Stock Options 120.26 2024-09-03 4 M 0 3266 0 D 2017-03-15 2026-03-15 Common Stock 3266 37570 D Stock Options 117.76 2024-09-03 4 M 0 3400 0 D 2021-03-15 2027-03-15 Common Stock 3400 150600 D Stock Options 120.26 2024-09-03 4 M 0 816 0 D 2017-03-15 2026-03-15 Common Stock 816 36754 D Stock Options 117.76 2024-09-03 4 M 0 850 0 D 2021-03-15 2027-03-15 Common Stock 850 149750 D This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 17, 2024. This option exercise was a "sell-to-cover" transaction whereby the reporting person exercised 816 stock options, sold 550 of the resulting shares of common stock, and held the remaining 266 shares of common stock. This option exercise was a "sell-to-cover" transaction whereby the reporting person exercised 850 stock options, sold 569 of the resulting shares of common stock, and held the remaining 281 shares of common stock. /s/ John S. Hess, Jr. under Power of Attorney 2024-09-04